In a 64-year-old man with difficulty staying asleep and frequent awakenings, what medications are recommended for sleep‑maintenance insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medications for Sleep Maintenance Insomnia in a 64-Year-Old Male

For this 64-year-old man with sleep maintenance insomnia (frequent awakenings), start with either suvorexant (10-20 mg), low-dose doxepin (3-6 mg), or eszopiclone (2-3 mg) as first-line pharmacologic options, with suvorexant or doxepin preferred given his age. 1

First-Line Medication Options for Sleep Maintenance

The 2017 American Academy of Sleep Medicine guidelines specifically identify medications effective for sleep maintenance insomnia 1:

Preferred Agents:

  • Suvorexant (orexin receptor antagonist): 10-20 mg at bedtime

    • Specifically recommended for sleep maintenance insomnia
    • Reduces wake after sleep onset and number of awakenings
    • Lower risk of cognitive impairment and motor effects compared to benzodiazepines 2, 1
  • Low-dose doxepin (heterocyclic): 3-6 mg at bedtime

    • Specifically indicated for sleep maintenance problems
    • Improves wake after sleep onset and total sleep time
    • Well-studied in older adults with favorable safety profile at low doses 1, 3
  • Eszopiclone (benzodiazepine receptor agonist): 2 mg at bedtime (start dose for age 64)

    • Effective for both sleep onset AND sleep maintenance
    • Reduces nocturnal awakenings and improves total sleep time
    • More evidence than other Z-drugs for sleep maintenance 1, 4

Alternative Options:

  • Zolpidem extended-release: Can address sleep maintenance but carries higher fall risk in older adults 1
  • Temazepam: 15 mg, but benzodiazepines have significant risks in this age group (falls, cognitive impairment, dependence) 1

Critical Age-Related Considerations

At age 64, this patient is approaching the threshold where medication risks increase substantially 2:

  • Reduced drug clearance increases sensitivity to sedative-hypnotics
  • Higher fall risk with benzodiazepines and some Z-drugs
  • Cognitive impairment risk more pronounced with benzodiazepines
  • Always start at lowest available dose and titrate cautiously 2

Medications to AVOID

Do NOT use 1, 5:

  • Trazodone (50 mg): Despite common off-label use, evidence shows no benefit for sleep maintenance and carries cardiac risks
  • Diphenhydramine/antihistamines: Anticholinergic effects particularly harmful in older adults; tolerance develops in 3-4 days
  • Benzodiazepines as routine therapy: High risk of dependence, falls, and cognitive impairment outweighs benefits
  • Melatonin: Not effective for sleep maintenance insomnia (only minimal benefit for sleep onset)
  • Tiagabine: Not effective and should not be used

Treatment Algorithm

Step 1: Before any medication, ensure behavioral interventions are addressed 2, 6:

  • Eliminate daytime napping (or limit to 30 minutes before 2 PM)
  • Avoid caffeine, nicotine, alcohol in evening
  • Maintain consistent sleep/wake times
  • Bedroom only for sleep and sex

Step 2: If pharmacotherapy needed, choose based on patient factors:

  • If concerned about next-day sedation or fall risk: Start doxepin 3 mg
  • If patient has no respiratory issues and wants newer agent: Start suvorexant 10 mg
  • If cost is a major concern: Eszopiclone 2 mg (generic available)

Step 3: Follow-up in 2-4 weeks to assess:

  • Effectiveness on wake after sleep onset and number of awakenings
  • Adverse effects (next-day sedation, dizziness, falls)
  • Need for dose adjustment

Step 4: If first agent ineffective, switch to alternate first-line agent rather than increasing dose 7

Step 5: Consider combining with cognitive behavioral therapy for insomnia (CBT-I) for sustained long-term benefit 2, 6

Important Safety Warnings

  • All hypnotics carry FDA warnings about next-day impairment, complex sleep behaviors ("sleep driving"), and behavioral changes 6
  • Observational data link chronic hypnotic use to increased dementia risk, fractures, and major injuries in older adults 6, 8
  • Use lowest effective dose and attempt to taper when conditions allow 7
  • Long-term use (beyond 4-5 weeks) should include regular monitoring for effectiveness and adverse effects 7, 6

Common Pitfall to Avoid

The most common error is prescribing trazodone because it's familiar and inexpensive. Despite widespread off-label use, the evidence shows it does not improve sleep maintenance outcomes and carries risks of orthostatic hypotension, cardiac arrhythmias, and priapism 1, 5. The 2017 AASM guidelines explicitly recommend AGAINST its use 1.

Related Questions

In an elderly patient with insomnia who uses tramadol as needed, what is the safest first‑line pharmacologic option for sleep?
What pharmacologic options are appropriate for managing sleep-onset insomnia in adults?
What pharmacologic options and dosing are recommended for insomnia in an elderly patient, and which agents should be avoided?
What is the best pharmacologic sleep aid for an elderly patient with maintenance insomnia who cannot use doxepin?
What is the recommended treatment for insomnia in an adult patient without hepatic or renal impairment and no contraindications?
For an 82‑kg patient with alcohol‑induced pancreatitis post‑necrosectomy on continuous total parenteral nutrition (TPN) containing 290 g dextrose and 20 units of regular insulin, with an insulin sensitivity factor (ISF) of 15 and blood glucose (BG) readings of 217 mg/dL at 2300, 235 mg/dL at 0300, and 179 mg/dL at 0700, how many insulin units should be added to the TPN?
Are organic beetroot capsules safe for a healthy adult to take?
What is the recommended management for a patient with type 2 diabetes on semaglutide who develops new visual disturbances such as blurred vision, floaters, vision loss, or eye pain?
What is the recommended management for a type 2 diabetic patient on semaglutide who develops optic nerve neuropathy?
How do I initiate a nicardipine intravenous infusion in a patient with a blood pressure of 200/100 mmHg?
What is the optimal antihypertensive therapy for a 51-year-old man with hypertension and hyperlipidemia who presents with temporal headaches and low back pain possibly related to metoprolol succinate extended-release 50 mg daily, considering his past tick bite treated with doxycycline and prior motor vehicle accident?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.